could semaglutide become a future treatment for alcohol use disorder?, A new randomized, double-blind, placebo-controlled trial published in The Lancet examined semaglutide 2.4 mg in treatment-seeking Will Semaglutide Give Me Energy?
Description
A clinical study showed that semaglutide (2.4 mg once weekly) reduced body weight by 10-15% of initial weight compared to 2-3% with placebo
To view a copy of this licence, visit About this article Cite this article Di Vincenzo, F., Del Gaudio, A., Petito, V
Zepbound is currently FDA-approved for the treatment of moderate to severe OSA in adults who: Its not intended for people with mild OSA or those who already manage their sleep apnea successfully through CPAP or other devices
PMID: 36606510
Adults During the COVID-19 Pandemic
)
Piro S, et al
